EGFR and central nervous system cancer: The GISTIC 2.0 assessment uncovered numerous remarkable amplified regions containing multiple oncogenes in glioma patients with higher risk scores, consisting of 1q32.1 (PIK3C2B), 12q14·1(CDK4), 7p11·2 (EGFR), and 4q12 (PDGFRA).